Literature DB >> 12668698

Aldosterone blockade and heart failure.

Mariell Jessup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668698     DOI: 10.1056/NEJMe030030

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Eplerenone : a review of its use in left ventricular systolic dysfunction and heart failure after acute myocardial infarction.

Authors:  Gillian M Keating; Greg L Plosker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?

Authors:  Osama A Ibrahim; Mark E Dunlap
Journal:  Curr Heart Fail Rep       Date:  2005-08

3.  Risk factors and outcomes in transfusion-associated circulatory overload.

Authors:  Edward L Murphy; Nicholas Kwaan; Mark R Looney; Ognjen Gajic; Rolf D Hubmayr; Michael A Gropper; Monique Koenigsberg; Greg Wilson; Michael Matthay; Peter Bacchetti; Pearl Toy
Journal:  Am J Med       Date:  2013-01-26       Impact factor: 4.965

4.  Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction.

Authors:  Carole Nadin
Journal:  Core Evid       Date:  2005-06-30

Review 5.  Inhibition of RAAS--when is it too much?

Authors:  Pablo Navarro; Robert Moskowitz; Thierry H Le Jemtel
Journal:  Curr Heart Fail Rep       Date:  2004-07

6.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2021-05-22

Review 7.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; James Thomas; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28

Review 8.  Gynecomastia and antihypertensive therapy.

Authors:  Ari Mosenkis; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-08       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.